←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Mitch Dowsett
PhD
🏢Royal Marsden Hospital / Institute of Cancer Research🌐UK
Professor of Biochemical Endocrinology
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mitch Dowsett established Ki67 as a core proliferation biomarker for endocrine-treated breast cancer. He led the IMPACT and POETIC studies defining Ki67 response as a prognostic window to endocrine sensitivity. His work underpins Ki67 use in neoadjuvant endocrine trials worldwide.
Share:
🧪Research Fields 研究领域
Ki67 biomarker
Endocrine therapy
Breast cancer biology
Aromatase inhibitors
Neoadjuvant biology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mitch Dowsett 的研究动态
Follow Mitch Dowsett's research updates
留下邮箱，当我们发布与 Mitch Dowsett（Royal Marsden Hospital / Institute of Cancer Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment